España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
ANI Pharmaceuticals
ANIP
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$61.44
0.62
1.02%
At Close: -
$61.44
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
ANI Pharmaceuticals (ANIP) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ANI Pharmaceuticals (NASDAQ:ANIP) Stock
ANI Pharmaceuticals Stock (NASDAQ: ANIP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 02, 2024
ANI Pharmaceuticals Announces FDA Approval An...
Benzinga Newsdesk
Wednesday, June 26, 2024
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on ANI Phar...
Benzinga Newsdesk
Tuesday, June 25, 2024
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
Avi Kapoor
Monday, June 24, 2024
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
Vandana Singh
ANI Pharma to Snap Alimera Sciences Valuing T...
Benzinga Newsdesk
Thursday, June 06, 2024
Insider Selling: Stephen P Carey Unloads $317K Of ANI Pharmaceuticals Stock
Benzinga Insights
Wednesday, May 22, 2024
Roche Cancer Drug Gets Breakthrough Therapy Designation
Zacks
Monday, May 20, 2024
ANI Pharmaceuticals Has Launched Kionex (Sodi...
Benzinga Newsdesk
Tuesday, May 14, 2024
Merck Ends Keytruda Combo Melanoma Study Due to Futility
Zacks
Monday, May 13, 2024
HC Wainwright & Co. Maintains Buy on ANI Phar...
Benzinga Newsdesk
Friday, May 10, 2024
ANI Pharmaceuticals Reiterates FY24 Outlook O...
Benzinga Newsdesk
ANI Pharmaceuticals Q1 Adj $1.21 Beats $1.00 ...
Benzinga Newsdesk
Thursday, May 09, 2024
Perrigo Q1 Earnings Surpass, Sales Miss Estimates
Zacks
Friday, May 03, 2024
Puma Biotechnology's Q1 Earnings and Revenues Beat
Zacks
Friday, April 26, 2024
Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
Zacks
Tuesday, April 23, 2024
Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts
Benzinga Insights
Guggenheim Reiterates Buy on ANI Pharmaceutic...
Benzinga Newsdesk
Thursday, April 11, 2024
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
Zacks
Tuesday, April 09, 2024
ANI Pharmaceuticals Announces The Launch Of B...
Benzinga Newsdesk
Wednesday, March 27, 2024
ANI Pharmaceuticals Announces the Launch of L...
Benzinga Newsdesk
Friday, March 15, 2024
Capital One Initiates Coverage On ANI Pharmac...
Benzinga Newsdesk
Tuesday, March 12, 2024
ANI Pharmaceuticals SVP & CFO Sold $510K In Company Stock
Benzinga Insights
Monday, March 11, 2024
Alphabet, Dover And 2 Other Stocks Insiders Are Selling
Avi Kapoor
Tuesday, March 05, 2024
Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts
Benzinga Insights
Guggenheim Maintains Buy on ANI Pharmaceutica...
Benzinga Newsdesk
Monday, March 04, 2024
HC Wainwright & Co. Maintains Buy on ANI Phar...
Benzinga Newsdesk
Friday, March 01, 2024
Truist Securities Maintains Buy on ANI Pharma...
Benzinga Newsdesk
Thursday, February 29, 2024
ANI Pharmaceuticals Forecasts 2024 Adjusted E...
Benzinga Newsdesk
ANI Pharmaceuticals Forecasts 2024 Purified C...
Benzinga Newsdesk
ANI Pharmaceuticals Forecasts 2024 Revenues O...
Benzinga Newsdesk
ANI Pharmaceuticals Q4 Adjusted EPS $1.00 Bea...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
ANI Pharmaceuticals's Earnings Outlook
Benzinga Insights
Friday, February 16, 2024
Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know
Benzinga Insights
Tuesday, January 23, 2024
ANI Pharmaceuticals Announced The Launch Of P...
Benzinga Newsdesk
Tuesday, January 16, 2024
ANI Pharma Bags FDA Approval and Launch of In...
Benzinga Newsdesk
Friday, November 17, 2023
ANI Pharmaceuticals SVP Trades $141K In Company Stock
Benzinga Insights
Wednesday, November 08, 2023
Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
Vandana Singh
ANI Pharmaceuticals shares are trading lower ...
Benzinga Newsdesk
CORRECTION: ANI Pharmaceuticals Sees FY23 Adj...
Benzinga Newsdesk
ANI Pharmaceuticals Sees FY23 Adj. EPS of $4....
Benzinga Newsdesk
ANI Pharmaceuticals Sees FY23 Revenue of $468...
Benzinga Newsdesk
ANI Pharmaceuticals Q3 Adjusted EPS $1.27 Bea...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Thursday, October 19, 2023
Expert Ratings for ANI Pharmaceuticals
Benzinga Insights
Guggenheim Reiterates Buy on ANI Pharmaceutic...
Benzinga Newsdesk
Monday, October 02, 2023
ANI Pharmaceuticals Announces FDA Approval, C...
Benzinga Newsdesk
Wednesday, September 13, 2023
Analyst Expectations for ANI Pharmaceuticals's Future
Benzinga Insights
Guggenheim Reiterates Buy on ANI Pharmaceutic...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch